3004390025
Other monotherapy formulations containing chorionic gonadotropin, luteinizing hormone, etc. (including growth hormone releasing peptides (GHRPs), pramerelin (growth hormone releasing peptide-2), CJC-1295 (CAS No. 863288-34-0), growth hormone releasing peptide-6, growth hormone releasing hormone and its analogues, growth hormone secretagogues, but excluding drugs that comply with anti-cancer and rare disease drug value-added tax policies)Unit | kilogram | Gen (General Tariff Rate) | 30 | MFN (Most-favored Nation) | 0 |
---|---|---|---|---|---|
TaxVAT (Value-added Tax): | 13 | Additional Tariff on U.S. Imports | Export Tax Rebate | 13 | |
Regulations & Restrictions | L | Inspection & Quarantine | Consumption Tax | ||
FTA (Free Trade Agreement Tax) | View | CCC Certificate | - | In-Quota on Imported Goods | 0 |
IT Origin Country Tariff | Anti-Dumping / Anti-Subsidy | - |
Customs Tariffs and Restrictions Information Integration System >>
Important Notice:
All the information, data and documents are provided by ETCN only for your reference. ETCN promises to collect and edit them in due care but shall not be liable for their correction and accuracy. In case of any discrepancy, official versions and interpretations shall prevail.
HS Code | Product Category | Categorial Description | Applicable Product | Applicable Standard |
---|
Country | Corporate name | Anti | Failure time | Countervailing | Failure time |
---|
: